Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer invests in gynaecological systems:

This article was originally published in Clinica

Executive Summary

Pfizer is to purchase privately-held Vesta Medical, developer of a system to treat menorrhagia. Terms were not disclosed. Vesta's procedure involves an inflatable balloon whose surface carries electrodes which, when inserted through a catheter into the uterus and inflated, electrosurgically removes the uterine lining. The treatment can be performed under local anaesthesia on an outpatient basis. Around one million women worldwide seek treatment for menorrhagia annually. Vesta's products will be manufactured and marketed by Valleylab, a subsidiary of Pfizer Hospital Products Group.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts